Towa Pharmaceutical Co., Ltd. (4553.T)

Growth (Per Share)

Revenue 5Y—
Revenue 3Y—
Earnings 5Y—
Earnings 3Y—
Dividend 5Y—
Dividend 3Y—

Capital Efficiency

ROIC—
ROE—
ROA—
ROTA—

Capital Structure

Market Cap87.58B
EV87.58B
Cash—
Current Ratio—
Debt/Equity—
Net Debt/EBITDA—
Show More

Select a metric from the list below to chart it

Income Statement
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
TTM
Revenue
457.5
532.9
612.3
633.4
696.6
783.7
823.1
1,155.0
1,234.9
1,345.2
Revenue % Chg.
11.1%
16.5%
14.9%
3.5%
10.0%
12.5%
5.0%
40.3%
6.9%
9.2%
Cost of Revenue
232.0
257.1
300.2
342.3
375.6
422.8
445.4
667.0
711.6
842.1
Gross Profit
225.4
275.8
312.1
291.1
321.0
360.9
377.6
488.0
523.3
503.1
Gross Profit Margin
49.3%
51.7%
51.0%
46.0%
46.1%
46.0%
45.9%
42.3%
42.4%
37.4%
Other Expenses
167.9
192.9
229.1
239.9
234.2
241.8
257.3
339.5
380.1
446.7
Operating Income
57.5
82.8
83.0
51.2
86.8
119.1
120.4
148.6
143.2
82.2
Operating Income Margin
12.6%
15.5%
13.6%
8.1%
12.5%
15.2%
14.6%
12.9%
11.6%
6.1%
Total Other Income/Expenses Net
7.4
30.6
-9.2
2.7
-13.5
21.8
34.0
-8.9
22.7
-42.7
Income Before Tax
64.9
113.4
73.8
54.0
73.3
140.8
154.4
139.6
165.9
39.4
Income Before Tax Margin
14.2%
21.3%
12.1%
8.5%
10.5%
18.0%
18.8%
12.1%
13.4%
2.9%
Income Tax Expense
20.2
30.5
16.5
12.4
24.9
40.3
46.3
35.6
47.2
17.8
Net Income
44.7
82.9
57.3
41.6
48.4
100.5
108.1
104.1
118.7
21.6
Net Income Margin
9.8%
15.6%
9.4%
6.6%
7.0%
12.8%
13.1%
9.0%
9.6%
1.6%
Weighted Avg. Shares Out
51.0
51.0
49.8
49.2
49.2
49.2
49.2
49.2
49.2
49.2
EPS
0.9
1.6
1.1
0.8
1.0
2.0
2.2
2.1
2.4
0.4
EPS % Chg.
-3.4%
85.5%
-29.3%
-26.5%
16.5%
107.5%
7.6%
-3.8%
14.0%
-85.1%
Weighted Avg. Shares Out Dil
51.0
51.0
52.8
53.2
53.2
53.2
53.2
51.3
50.3
50.1
EPS Diluted
0.9
1.6
1.1
0.8
0.9
1.9
2.0
2.0
2.4
0.4
Interest Income
0.3
0.8
0.8
0.2
0.4
0.4
0.6
0.2
0.1
0.1
Interest Expense
0.9
1.0
1.2
1.2
1.2
1.1
1.0
1.4
1.7
4.3
EBIT
64.3
113.2
73.4
53.0
72.6
140.1
154.0
138.4
164.2
35.3
EBIT Margin
14.1%
21.2%
12.0%
8.4%
10.4%
17.9%
18.7%
12.0%
13.3%
2.6%
Depreciation & Amortization
40.3
42.7
54.6
59.5
60.9
62.2
71.3
87.6
93.1
-12.7
EBITDA
104.6
155.9
128.0
112.5
133.5
202.3
225.3
226.0
257.3
22.6
EBITDA Margin
22.9%
29.3%
20.9%
17.8%
19.2%
25.8%
27.4%
19.6%
20.8%
1.7%